Determining Anti-cancer Efficacy of a Reversible LSD1 Inhibitor, EXS74539, in Primary AML Tissues with Limited Thrombocytopenic Effects

October 21, 2023
Written By:
No items found.
Read the post ›

Decoding biology to radically improve lives.®

Proud founding member of BioHive, the fastest growing life sciences community in the nation

Get In Touch

41 S Rio Grande Street
Salt Lake City, UT 84101
phone: (385) 269-0203
Investor Relations

Policies

Website Terms of Use
Privacy Policy
Vendor Expectations Manual & Resources
Accessibility

Connect

LinkedIn
X
Instagram
Youtube
Facebook
Bluesky